文献速递泌尿生殖MR

德国健康男性PSA、PSAD与MRI前列腺体积参考值

Reference values for PSA, PSA density, and MRI prostate volume in healthy German men.
PubMed 文献 · Eur Radiol · 2026-09-25

基于德国波美拉尼亚健康研究1037例无前列腺疾病男性,利用MRI深度学习分割获得前列腺体积并计算PSA及PSAD,按年龄、BMI、身高分层建模。结果显示PSAD随年龄相对稳定且年龄校正后不超过0.11 ng/mL²,而PSA持续上升,并提供了开源计算器。

要点

  • PSAD年龄稳定性优于PSA,年龄校正后始终低于0.11 ng/mL²,可用于筛查分层。
  • PSA与前列腺体积百分位曲线可帮助区分正常变异与病理改变,避免过度评估。
  • MRI分割体积与手动体积在测试集比较,临床报告可参考体积95百分位51.39 mL。

核心结论

  • PSAD具有年龄稳定性,年龄校正后不超过0.11 ng/mL²,而PSA随年龄持续上升,参考值可辅助区分正常与病理改变。
  • 提供了PV、PSA、PSAD的参照值和百分位曲线及开源计算器,可支持个体化评估。

研究设计与样本

  • 研究类型为基于前瞻性人群队列「波美拉尼亚健康研究」的横断面分析,随访10年。
  • 共纳入1037例德国男性,中位年龄46.00岁(IQR 38.00–56.00),排除前列腺癌、良性前列腺增生和下尿路症状。
  • 前列腺体积和PSAD来自盆腔MRI,采用深度学习分割;测试集中与手动勾画体积比较。
  • 使用广义可加位置尺度形状模型按年龄、BMI、身高对PV、PSA、PSAD建模。

关键影像表现/征象

  • 中位前列腺体积31.29 mL,95%区间20.74–51.39;PSA中位0.81 ng/mL,95%区间0.32–2.79。

诊断标准与关键数值

  • PSAD中位数0.025 ng/mL²,95%区间0.011–0.071,PSAD在71岁达峰值后75岁前平台再下降。
  • 年龄校正后PSAD未超过0.11 ng/mL²,PSA持续升高;BMI与前列腺体积正相关、与PSAD负相关,PSA与身高负相关。

临床应用与阅片要点

  • 阅片报告中可结合年龄分层参考百分位判断前列腺体积和PSAD是否超出正常范围。
  • PSAD参考值可用于筛查中辅助决策,减少不必要的前列腺穿刺或进一步检查。
  • 利用开源计算器可校正年龄、BMI、身高后综合评估PSA、PSAD和体积。

局限性

  • 男性来自德国波美拉尼亚地区人群,结果外推到其他种族的适用性未明。
  • 排除前列腺癌、良性前列腺增生及下尿路症状者,参考值不能反映合并下尿路症状人群。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To establish stratified normative reference values for MRI-derived prostate volume (PV), prostate-specific antigen (PSA), and PSA density (PSAD) in German men with no known prostate pathologies, accounting for age, body-mass index, and height.

MATERIALS AND METHODS: This study included men from the prospective population-based Study of Health in Pomerania, Germany, with 10 years of follow-up. Men with diagnosed prostate cancer, benign prostatic hyperplasia, or lower urinary tract symptoms were excluded to derive reference values unaffected by disease or interventions. PV and PSAD were obtained from pelvic MRI using deep-learning segmentation. In a test set, segmentation-derived volumes were compared with manual PVs. PV, PSA, and PSAD were modeled using generalized additive models for location, scale, and shape (GAMLSS).

RESULTS: Out of 1696 men, 1037 were analyzed (median age 46.00 years [IQR 38.00-56.00]). Median PV was 31.29 mL (5th-95th: 20.74-51.39), PSA 0.81 ng/mL (0.32-2.79), and PSAD 0.025 ng/mL² (0.011-0.071). PV and PSA increased progressively with age, whereas PSAD showed greater age-stability, peaking at 71 years, plateauing until 75, and then declining. Age-adjusted PSAD never exceeded 0.11 ng/mL², unlike PSA, which rose continuously. Body-mass index correlated positively with PV but inversely with PSAD; PSA showed a negative association with height.

CONCLUSION: This study provides reference values and percentile curves for PV, PSA, and PSAD in men without prostate disease, along with an open-access calculator. PSAD showed age-stability, contrasting with continuously rising PSA. These reference values may help distinguish normal from pathological prostatic variation across age strata and inform PSAD thresholds in screening programs.

KEY POINTS: Question Population-based reference values with long-term follow-up for PV, PSA, and PSAD are lacking, limiting the distinction between normal variation and disease-related changes. Findings Among 1037 men without prostate disease, 95th percentiles were: PV 51.39 mL, PSA 2.79 ng/mL, and PSAD 0.071 ng/mL². PSAD remained below 0.11 ng/mL² across all age ranges. Clinical relevance MRI-based percentiles for PV and PSAD may help identify normal variation, reducing unnecessary evaluations while supporting early detection of abnormalities. An open-access calculator enables personalized assessment for clinical and research purposes.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Lindholz, Schoots, Bülow, et al. Reference values for PSA, PSA density, and MRI prostate volume in healthy German men. Eur Radiol. 2026. PMID: 42789055. doi:10.1007/s00330-026-12937-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。